Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|September 7, 2021
A Genome-Scale Antibiotic Screen in Serratia marcescens Identifies YdgH as a Conserved Modifier of Cephalosporin and Detergent SusceptibilityJacob E Lazarus, Alyson R Warr, Kathleen A Westervelt, et al.The Journal of Antibiotics|February 24, 2001
A potent seryl tRNA synthetase inhibitor SB-217452 isolated from a Streptomyces speciesA L Stefanska, M Fulston, C S Houge-Frydrych, et al.Journal of Agricultural, Biological, and Environmental Statistics|February 13, 2023
Distributional Validation of Precipitation Data Products with Spatially Varying Mixture ModelsLynsie R Warr, Matthew J Heaton, William F Christensen, et al.Journal of the American College of Cardiology|June 25, 2003
Prevalence of "silent" pulmonary emboli in adults after the Fontan operationChetan Varma, Matthew R Warr, Aaron L Hendler, et al.Genes & Development|August 20, 2011
Validation of MdmX as a therapeutic target for reactivating p53 in tumorsDaniel Garcia, Matthew R Warr, Carla P Martins, et al.Nature|February 8, 2013
FOXO3A directs a protective autophagy program in haematopoietic stem cellsMatthew R Warr, Mikhail Binnewies, Johanna Flach, et al.International Journal of Cancer|November 5, 1997
Sub-lethal effects of exposing the human melanoma cell line SKmel-23 to 532 nm laser lightN W Zhu, J Kenealy, A Burd, et al.The Journal of Antibiotics|June 24, 2000
SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp. I. Fermentation, isolation and propertiesA L Stefanska, N J Coates, L M Mensah, et al.Applied and Environmental Microbiology|June 16, 2019
A New Suite of Allelic-Exchange Vectors for the Scarless Modification of Proteobacterial GenomesJacob E Lazarus, Alyson R Warr, Carole J Kuehl, et al.FEBS Letters|October 11, 2005
BH3-ligand regulates access of MCL-1 to its E3 ligaseMatthew R Warr, Stephane Acoca, Zhiqian Liu, et al.Pageof 7